Its mission is to provide the highest level of quality and cutting-edge services to facilitate and advance the definition of the best therapy for the patient and close the cycle from basic research to the completion of the clinical application.

In 2002, the Oncology Plan of Catalonia promoted the creation of a network of tumor banks in Catalonia that would serve to provide sufficient samples for cancer research and to obtain useful results in the diagnosis and treatment of these patients. One of the most important resources for the development of these studies are tumor tissues and other samples (serum, cell cultures) from patients affected by this disease as well as healthy control tissues. From these types of samples it is possible to obtain DNA, RNA, proteins and other products useful for research.

European infrastructure for translational medicine. We pool resources and services for research communities to translate scientific discoveries into benefits for patients.

Mission: to develop cooperative actions of excellence in the double field of translational cardiovascular research and training. These actions are aimed at the exploitation, attraction and retention of talent, and must lead to the clarification of the mechanisms of cardiovascular disease and the benefits that can be transferred to the diagnosis, prevention, cure or palliation of talent. 'this pathology and its sequelae. They must also contribute to the prosperity of our society, helping to protect the health of our citizens, contributing to the generation of employment and supporting the development of the biomedical industry within our borders.

Mission: to create a stable network research structure in this area to allow the promotion of research and technical activity in a horizontal field of human health and, thus, to establish the essential bases for the development of the Public Health policies of the different responsible administrations. of the National Health System. This requires the coordination, collaboration and strategic and economic management of research groups distributed throughout the geography.

Mission: CIBEREHD is a consortium with its own legal personality, without physical contiguity, which aims to promote and collaborate in scientific research, development of knowledge and its transfer to society, in the area of ​​liver and digestive diseases.

SCReN: Support for multicenter clinical trials Achieve an advanced level of technical competence in the processes related to the development and management of clinical research, ensure compliance with legal requirements and the competence of researchers participating in platform studies on methodological aspects and PCBs. others.

REGIC is the first association of clinical research management organizations created in Spain at the request of professionals, to share experiences and create a space for interaction and training in the management of healthcare R & D & I.

The BCTP has as its great challenge to advance the arrival of innovative treatments to patients in Catalonia. BCTP needs to improve the coordination, integration, quality, inclusiveness and speed of clinical research. This will be thanks to the optimization and homogenization of the clinical research processes of its members, as well as the human and technological potential of the centers. In addition, the BCTP will function as a dissemination platform to attract new studies from outside Catalonia.

The Center for Genomic Regulation (CRG) has partnered with several leading hospital research institutes in Catalonia to create a new state-of-the-art infrastructure to study and analyze proteins. It is the first such collaboration between biomedical research institutes and hospitals. The state-of-the-art equipment acquired will help meet the growing demand for protein analysis from Catalan research and innovation institutions.